Upgrade to SI Premium - Free Trial

Molina Healthcare Reports Third Quarter 2019 Financial Results

October 29, 2019 4:15 PM

Raises Full Year 2019 Earnings Guidance

LONG BEACH, Calif.--(BUSINESS WIRE)-- Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the third quarter of 2019 of $175 million, or $2.75 per diluted share, compared to net income of $197 million, or $2.90 per diluted share, in the third quarter of 2018. Financial results for the third quarter of 2019 are summarized below:

Three Months Ended

Nine Months Ended

September 30,

September 30,

2019

2018

2019

2018

(In millions, except per share results)

Premium Revenue

$4,084

$4,337

$12,085

$13,174

Total Revenue

$4,243

$4,697

$12,555

$14,226

Pre-Tax Income

$233

$259

$750

$743

Net Income

$175

$197

$569

$506

EPS - Diluted

$2.75

$2.90

$8.80

$7.60

MCR

86.3%

87.4%

85.7%

86.2%

G&A Ratio

7.6%

6.6%

7.6%

7.0%

Pre-Tax Margin

5.5%

5.5%

6.0%

5.2%

Effective Tax Rate

24.7%

24.0%

24.1%

31.9%

After-Tax Margin

4.1%

4.2%

4.5%

3.6%

Highlights include:

“We are pleased with our performance this quarter as we sustained our margin profile, produced significant excess capital, and increased our full year 2019 guidance,” said Joe Zubretsky, president and CEO. “We have accomplished this in the backdrop of commencing our pivot to growth.”

Premium Revenue

Premium revenue for the third quarter of 2019 decreased 5.8% to $4.1 billion compared to $4.3 billion in the third quarter of 2018, which was in line with the Company’s expectations.

For the nine months ended September 30, 2019, premium revenue decreased 8.3% to $12.1 billion, from $13.2 billion for the comparable period in 2018. In both periods, the lower premium revenue is primarily a result of previously announced losses of Medicaid membership in New Mexico and Florida.

Medical Care Ratio

The consolidated MCR for the third quarter of 2019 was 86.3% compared to 87.4% in the third quarter of 2018. Prior period reserve development in the quarter was negligible.

The MCR for the nine months ended September 30, 2019, improved to 85.7% compared to 86.2% for the comparable period in 2018, due to a combination of the following:

General and Administrative Expense Ratio

The general and administrative expenses were 7.6% of total revenues in the third quarter of 2019 compared to 6.6% in the third quarter of 2018.

For the nine months ended September 30, 2019, the G&A ratio was 7.6% compared to 7.0% in the comparable prior-year period. In both periods, the year-over-year increases are due mainly to the year-over-year decline in total revenues.

Interest Expense

Interest expense was $22 million in the third quarter of 2019 compared to $26 million in the third quarter of 2018. The decline was due to continued repayment of convertible notes.

Other Expenses

The third quarter results included a $2 million charge on the repayment of convertible notes, resulting in a $0.03 net loss per diluted share.

Balance Sheet

Cash and investments at the parent company amounted to $796 million as of September 30, 2019, compared to $467 million as of June 30, 2019.

During the third quarter of 2019, the parent company received $430 million of dividends from the regulated health plan subsidiaries.

The Company repaid $55 million of principal on the convertible notes during the quarter, and $240 million since the beginning of the year. The impact of capital deployment actions in the quarter resulted in lower interest expense, a slight loss on repayment of the convertible notes, and a lower share count.

Cash Flow

Operating cash flows for the nine months ended September 30, 2019, amounted to $398 million and were higher compared to the nine months ended September 30, 2018, primarily due to the normal fluctuations of working capital.

Outlook

The Company raised its full year 2019 earnings guidance range to $11.30 - $11.55 per diluted share, from previously issued guidance of $11.20 - $11.50.

Guidance is based on the following:

October 29, 2019 (1)

July 30, 2019 (1)

(current)

(previous)

Premium revenue

$16.1B

$16.1B

Medicaid

$12.4B

$12.3B

Medicare

$2.2B

$2.2B

Marketplace

$1.5B

$1.6B

Premium tax revenue

$565M

$450M

Investment income and other revenue

$135M

$115M

Total revenue

$16.8B

$16.7B

Medical care costs

$13.8B

$13.8B

General and administrative expenses

$1.3B

$1.3B

Premium tax expenses

$565M

$450M

EBITDA (2)

$1,140M - $1,160M

$1,135M - $1,160M

Depreciation and amortization

$90M

$90M

Interest expense and other expenses, net

$90M

$90M

Income before income taxes

$960M - $980M

$955M - $980M

Net income

$725M - $740M

$725M - $740M

Net income per share

$11.30 - $11.55

$11.20 - $11.50

Diluted weighted average shares

64.2M

64.5M

End-of-year membership:

Medicaid and Medicare

3.1M

3.1M

Marketplace

270K

270K - 280K

Operating Statistics:

Medical care ratio

86%

86%

G&A ratio

7.7%

7.7%

Effective income tax expense rate

24.3%

24.2%

After-tax margin

4.3% - 4.4%

4.2% - 4.4%

Medicaid

3%

3%

Medicare

7%

7%

Marketplace

11%

11%

__________________

(1) All amounts are rounded and approximations.
(2) See reconciliation of non-GAAP financial measures at the end of this release.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s third quarter 2019 results at 8:00 a.m. Eastern time on Wednesday, October 30, 2019. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 5680857. A telephonic replay of the conference call will be available through Wednesday, November 6, 2019, by dialing (877) 344-7529 and entering confirmation number 10135133. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30‑day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.3 million members as of September 30, 2019. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release contains forward-looking statements regarding the Company’s revised 2019 guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those risks and uncertainties are discussed in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and the section entitled “Forward-Looking Statements” in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2019.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of October 29, 2019, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended

Nine Months Ended

September 30,

September 30,

2019

2018

2019

2018

(In millions, except per-share amounts)

Revenue:

Premium revenue

$

4,084

$

4,337

$

12,085

$

13,174

Premium tax revenue

119

110

367

320

Health insurer fees reimbursed

83

248

Service revenue

130

391

Investment income and other revenue

40

37

103

93

Total revenue

4,243

4,697

12,555

14,226

Operating expenses:

Medical care costs

3,523

3,790

10,360

11,362

General and administrative expenses

323

311

953

998

Premium tax expenses

119

110

367

320

Health insurer fees

87

261

Depreciation and amortization

21

25

68

76

Restructuring costs

5

5

38

Cost of service revenue

111

349

Total operating expenses

3,986

4,439

11,753

13,404

Gain on sale of subsidiary

37

37

Operating income

257

295

802

859

Other expenses, net:

Interest expense

22

26

67

91

Other expenses (income), net

2

10

(15

)

25

Total other expenses, net

24

36

52

116

Income before income tax expense

233

259

750

743

Income tax expense

58

62

181

237

Net income

$

175

$

197

$

569

$

506

Net income per share, diluted

$

2.75

$

2.90

$

8.80

$

7.60

Diluted weighted average shares outstanding

63.6

67.9

64.6

66.6

Operating Statistics:

Medical care ratio

86.3

%

87.4

%

85.7

%

86.2

%

G&A ratio

7.6

%

6.6

%

7.6

%

7.0

%

Premium tax ratio

2.8

%

2.5

%

2.9

%

2.4

%

Effective income tax rate

24.7

%

24.0

%

24.1

%

31.9

%

After-tax margin

4.1

%

4.2

%

4.5

%

3.6

%

Medicaid

3.4

%

2.8

%

3.1

%

2.0

%

Medicare

6.4

%

1.4

%

7.0

%

3.7

%

Marketplace

8.1

%

15.3

%

11.9

%

16.7

%

CONSOLIDATED BALANCE SHEETS

September 30,

December 31,

2019

2018

Unaudited

(Dollars in millions,
except per-share amounts)

ASSETS

Current assets:

Cash and cash equivalents

$

2,679

$

2,826

Investments

1,757

1,681

Receivables

1,280

1,330

Prepaid expenses and other current assets

140

149

Derivative asset

21

476

Total current assets

5,877

6,462

Property, equipment, and capitalized software, net

379

241

Goodwill and intangible assets, net

176

190

Restricted investments

79

120

Deferred income taxes

82

117

Other assets

108

24

$

6,701

$

7,154

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Medical claims and benefits payable

$

1,975

$

1,961

Amounts due government agencies

612

967

Accounts payable and accrued liabilities

478

390

Deferred revenue

207

211

Current portion of long-term debt

15

241

Derivative liability

21

476

Total current liabilities

3,308

4,246

Long-term debt

1,239

1,020

Finance lease liabilities

233

197

Other long-term liabilities

90

44

Total liabilities

4,870

5,507

Stockholders’ equity:

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 63 million shares at September 30, 2019 and 62 million shares at December 31, 2018

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

Additional paid-in capital

160

643

Accumulated other comprehensive income (loss)

5

(8

)

Retained earnings

1,666

1,012

Total stockholders’ equity

1,831

1,647

$

6,701

$

7,154

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended

Nine Months Ended

September 30,

September 30,

2019

2018

2019

2018

(In millions)

Operating activities:

Net income

$

175

$

197

$

569

$

506

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

Depreciation and amortization

21

31

68

104

Deferred income taxes

(12

)

(26

)

7

(32

)

Share-based compensation

10

7

29

20

Amortization of convertible senior notes and finance lease liabilities

1

5

5

18

Loss (gain) on debt repayment

2

10

(15

)

25

Gain on sale of subsidiary

(37

)

(37

)

Non-cash restructuring costs

17

Other, net

(8

)

2

(5

)

6

Changes in operating assets and liabilities:

Receivables

(41

)

(192

)

50

(507

)

Prepaid expenses and other current assets

(24

)

64

(6

)

(117

)

Medical claims and benefits payable

208

123

14

(144

)

Amounts due government agencies

(372

)

(716

)

(355

)

(511

)

Accounts payable and accrued liabilities

98

49

37

398

Deferred revenue

177

(13

)

(4

)

(55

)

Income taxes

7

(9

)

4

118

Net cash provided by (used in) operating activities

242

(505

)

398

(191

)

Investing activities:

Purchases of investments

(776

)

(288

)

(1,938

)

(1,202

)

Proceeds from sales and maturities of investments

1,099

735

1,890

2,070

Purchases of property, equipment, and capitalized software

(10

)

(10

)

(30

)

(24

)

Other, net

(14

)

(2

)

(23

)

Net cash provided by (used in) investing activities

313

423

(80

)

821

Financing activities:

Repayment of principal amount of 1.125% Convertible Notes

(55

)

(140

)

(240

)

(236

)

Cash paid for partial settlement of 1.125% Conversion Option

(105

)

(343

)

(578

)

(477

)

Cash received for partial termination of 1.125% Call Option

105

343

578

477

Cash paid for partial termination of 1.125% Warrants

(90

)

(306

)

(514

)

(419

)

Proceeds from borrowings under Term Loan Facility

220

Repayment of Credit Facility

(300

)

Repayment of 1.625% Convertible Notes

(64

)

(64

)

Other, net

(3

)

1

24

7

Net cash used in financing activities

(148

)

(509

)

(510

)

(1,012

)

Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents

407

(591

)

(192

)

(382

)

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

2,327

3,499

2,926

3,290

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

2,734

$

2,908

$

2,734

$

2,908

HEALTH PLANS SEGMENT MEMBERSHIP

September 30,

2019

December 31,

2018

September 30,

2018

Ending Membership by Government Program:

TANF and CHIP

1,993,000

2,295,000

2,436,000

Medicaid Expansion

598,000

660,000

664,000

ABD

364,000

406,000

415,000

Total Medicaid

2,955,000

3,361,000

3,515,000

MMP - Integrated

58,000

54,000

55,000

Medicare Special Needs Plans

44,000

44,000

45,000

Total Medicare

102,000

98,000

100,000

Total Medicaid and Medicare

3,057,000

3,459,000

3,615,000

Marketplace

289,000

362,000

384,000

3,346,000

3,821,000

3,999,000

Ending Membership by Health Plan:

California

580,000

608,000

623,000

Florida (1)

136,000

313,000

395,000

Illinois

224,000

224,000

223,000

Michigan

361,000

383,000

394,000

New Mexico (1)

24,000

222,000

234,000

Ohio

292,000

302,000

315,000

Puerto Rico

186,000

252,000

320,000

South Carolina

134,000

120,000

117,000

Texas

350,000

423,000

436,000

Washington

818,000

781,000

770,000

Other (2)

241,000

193,000

172,000

3,346,000

3,821,000

3,999,000

__________________

(1) The Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. During 2019, the Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida.
(2) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

UNAUDITED SELECTED FINANCIAL DATA
(In millions, except percentages and per-member per-month amounts)
HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM

Member

Months (1)

Premium Revenue

Medical Care Costs

MCR (2)

Medical

Margin

Total

PMPM

Total

PMPM

Three Months Ended September 30, 2019

TANF and CHIP

6.0

$

1,225

$

202.46

$

1,071

$

176.88

87.4

%

$

154

Medicaid Expansion

1.8

696

385.63

622

345.25

89.5

74

ABD

1.1

1,247

1,136.67

1,097

1,000.56

88.0

150

Total Medicaid

8.9

3,168

353.81

2,790

311.70

88.1

378

MMP

0.2

399

2,328.70

345

2,010.50

86.3

54

Medicare

0.1

160

1,230.01

134

1,029.75

83.7

26

Total Medicare

0.3

559

1,854.96

479

1,587.61

85.6

80

Total Medicaid and Medicare

9.2

3,727

402.76

3,269

353.31

87.7

458

Marketplace

0.9

357

410.23

254

292.21

71.2

103

10.1

$

4,084

$

403.40

$

3,523

$

348.06

86.3

%

$

561

Three Months Ended September 30, 2018

TANF and CHIP

7.4

$

1,379

$

187.03

$

1,228

$

166.41

89.0

%

$

151

Medicaid Expansion

2.0

671

333.11

640

317.62

95.3

31

ABD

1.2

1,322

1,054.92

1,186

946.38

89.7

136

Total Medicaid

10.6

3,372

316.86

3,054

286.86

90.5

318

MMP

0.2

353

2,159.72

323

1,981.45

91.7

30

Medicare

0.1

156

1,157.71

121

895.25

77.3

35

Total Medicare

0.3

509

1,706.95

444

1,490.63

87.3

65

Total Medicaid and Medicare

10.9

3,881

354.70

3,498

319.63

90.1

383

Marketplace

1.2

456

394.02

292

252.61

64.1

164

12.1

$

4,337

$

358.46

$

3,790

$

313.23

87.4

%

$

547

Nine Months Ended September 30, 2019

TANF and CHIP

18.3

$

3,594

$

196.01

$

3,141

$

171.30

87.4

%

$

453

Medicaid Expansion

5.4

2,055

380.08

1,810

334.85

88.1

245

ABD

3.3

3,590

1,097.94

3,200

978.64

89.1

390

Total Medicaid

27.0

9,239

342.03

8,151

301.77

88.2

1,088

MMP

0.5

1,193

2,368.38

1,034

2,051.90

86.6

159

Medicare

0.4

489

1,270.32

399

1,037.24

81.7

90

Total Medicare

0.9

1,682

1,892.63

1,433

1,612.29

85.2

249

Total Medicaid and Medicare

27.9

10,921

391.44

9,584

343.53

87.8

1,337

Marketplace

2.8

1,164

414.17

776

276.28

66.7

388

30.7

$

12,085

$

393.52

$

10,360

$

337.37

85.7

%

$

1,725

Nine Months Ended September 30, 2018

TANF and CHIP

22.3

$

4,145

$

186.12

$

3,705

$

166.35

89.4

%

$

440

Medicaid Expansion

6.1

2,184

359.37

1,957

322.01

89.6

227

ABD

3.7

3,864

1,034.25

3,550

950.11

91.9

314

Total Medicaid

32.1

10,193

317.70

9,212

287.10

90.4

981

MMP

0.5

1,077

2,173.90

941

1,899.26

87.4

136

Medicare

0.4

470

1,171.59

385

959.54

81.9

85

Total Medicare

0.9

1,547

1,725.71

1,326

1,479.06

85.7

221

Total Medicaid and Medicare

33.0

11,740

355.96

10,538

319.50

89.8

1,202

Marketplace

3.8

1,434

379.91

824

218.44

57.5

610

36.8

$

13,174

$

358.42

$

11,362

$

309.12

86.2

%

$

1,812

__________________

(1) A member month is defined as the aggregate of each month’s ending membership for the period presented.
(2) The MCR represents medical costs as a percentage of premium revenue.

HEALTH PLANS SEGMENT FINANCIAL DATA — MEDICAID AND MEDICARE

Member

Months

Premium Revenue

Medical Care Costs

MCR

Medical

Margin

Total

PMPM

Total

PMPM

Three Months Ended September 30, 2019

California

1.6

$

510

$

315.90

$

423

$

261.97

82.9

%

$

87

Florida

0.3

130

436.99

127

427.80

97.9

3

Illinois

0.7

257

383.41

232

347.28

90.6

25

Michigan

1.1

401

373.01

332

307.97

82.6

69

Ohio

0.9

615

687.38

563

628.98

91.5

52

Puerto Rico

0.6

117

209.25

102

182.53

87.2

15

South Carolina

0.4

151

379.20

138

347.23

91.6

13

Texas

0.7

592

912.76

540

833.51

91.3

52

Washington

2.3

643

269.52

570

238.55

88.5

73

Other (1) (2)

0.6

311

437.60

242

341.29

78.0

69

9.2

$

3,727

$

402.76

$

3,269

$

353.31

87.7

%

$

458

Three Months Ended September 30, 2018

California

1.7

$

435

$

249.00

$

446

$

255.22

102.5

%

$

(11

)

Florida

1.0

388

363.16

362

339.33

93.4

26

Illinois

0.7

207

312.72

182

274.98

87.9

25

Michigan

1.1

397

350.05

321

282.49

80.7

76

New Mexico (2)

0.6

304

471.66

275

426.69

90.5

29

Ohio

0.9

584

624.84

532

568.93

91.1

52

Puerto Rico

1.0

179

189.65

162

171.96

90.7

17

South Carolina

0.4

124

354.53

112

318.56

89.9

12

Texas

0.7

577

848.47

525

772.14

91.0

52

Washington

2.3

511

226.77

444

197.04

86.9

67

Other (1)

0.5

175

334.29

137

261.49

78.2

38

10.9

$

3,881

$

354.70

$

3,498

$

319.63

90.1

%

$

383

Nine Months Ended September 30, 2019

California

4.9

$

1,508

$

306.96

$

1,286

$

261.76

85.3

%

$

222

Florida

1.0

418

410.71

374

367.95

89.6

44

Illinois

2.0

726

365.35

632

318.26

87.1

94

Michigan

3.3

1,199

370.77

990

305.99

82.5

209

Ohio

2.7

1,835

682.59

1,653

614.89

90.1

182

Puerto Rico

1.8

341

190.42

301

167.98

88.2

40

South Carolina

1.2

427

368.35

378

326.61

88.7

49

Texas

2.0

1,789

910.64

1,623

826.20

90.7

166

Washington

7.1

1,868

261.92

1,691

236.98

90.5

177

Other (1) (2)

1.9

810

402.31

656

325.93

81.0

154

27.9

$

10,921

$

391.44

$

9,584

$

343.53

87.8

%

$

1,337

Nine Months Ended September 30, 2018

California

5.3

$

1,446

$

270.63

$

1,299

$

243.14

89.8

%

$

147

Florida

3.2

1,147

356.15

1,069

331.93

93.2

78

Illinois

1.8

551

308.45

474

265.47

86.1

77

Michigan

3.4

1,161

343.08

983

290.26

84.6

178

New Mexico (2)

2.0

936

469.19

875

438.70

93.5

61

Ohio

2.8

1,670

590.71

1,474

521.26

88.2

196

Puerto Rico

2.9

549

190.34

501

173.83

91.3

48

South Carolina

1.1

369

350.94

323

306.76

87.4

46

Texas

2.1

1,715

831.21

1,554

753.31

90.6

161

Washington

6.8

1,666

245.40

1,544

227.41

92.7

122

Other (1)

1.6

530

323.84

442

269.98

83.4

88

33.0

$

11,740

$

355.96

$

10,538

$

319.50

89.8

%

$

1,202

_______________

(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.
(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

HEALTH PLANS SEGMENT FINANCIAL DATA — MARKETPLACE

Member

Months

Premium Revenue

Medical Care Costs

MCR

Medical

Margin

Total

PMPM

Total

PMPM

Three Months Ended September 30, 2019

California

0.2

$

57

$

371.07

$

33

$

210.87

56.8

%

$

24

Florida

0.1

41

349.53

25

212.00

60.7

16

Michigan

7

431.41

4

289.45

67.1

3

Ohio

25

792.96

19

626.30

79.0

6

Texas

0.4

142

351.04

105

257.68

73.4

37

Washington

0.1

45

719.67

33

548.75

76.2

12

Other (1)

0.1

40

480.41

35

408.35

85.0

5

0.9

$

357

$

410.23

$

254

$

292.21

71.2

%

$

103

Three Months Ended September 30, 2018

California

0.2

$

49

$

309.04

$

37

$

235.63

76.2

%

$

12

Florida

0.2

66

548.60

45

362.39

66.1

21

Michigan

12

233.51

7

145.13

62.1

5

New Mexico

0.1

28

419.20

18

249.33

59.5

10

Ohio

0.1

27

485.08

18

336.86

69.4

9

Texas

0.6

228

357.54

134

209.80

58.7

94

Washington

44

656.70

34

518.75

79.0

10

Other (2)

2

NM

(1

)

NM

NM

3

1.2

$

456

$

394.02

$

292

$

252.61

64.1

%

$

164

Nine Months Ended September 30, 2019

California

0.5

$

174

$

364.72

$

101

$

210.76

57.8

%

$

73

Florida

0.4

152

389.44

81

207.22

53.2

71

Michigan

27

474.12

15

265.95

56.1

12

Ohio

0.1

79

801.90

53

543.00

67.7

26

Texas

1.3

457

344.19

331

249.44

72.5

126

Washington

0.2

143

744.47

97

509.50

68.4

46

Other (1)

0.3

132

494.59

98

364.71

73.7

34

2.8

$

1,164

$

414.17

$

776

$

276.28

66.7

%

$

388

Nine Months Ended September 30, 2018

California

0.6

$

171

$

326.82

$

89

$

169.98

52.0

%

$

82

Florida

0.5

211

491.13

67

155.24

31.6

144

Michigan

0.1

40

248.24

23

145.38

58.6

17

New Mexico

0.2

93

426.07

55

247.57

58.1

38

Ohio

0.2

84

466.75

58

324.91

69.6

26

Texas

2.0

679

330.92

440

214.65

64.9

239

Washington

0.2

139

654.78

105

497.00

75.9

34

Other (2)

17

NM

(13

)

NM

NM

30

3.8

$

1,434

$

379.91

$

824

$

218.44

57.5

%

$

610

__________________

(1) “Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019.

(2) “Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM).

HEALTH PLANS SEGMENT FINANCIAL DATA — TOTAL

Member

Months

Premium Revenue

Medical Care Costs

MCR

Medical

Margin

Total

PMPM

Total

PMPM

Three Months Ended September 30, 2019

California

1.8

$

567

$

320.67

$

456

$

257.55

80.3

%

$

111

Florida

0.4

171

412.29

152

366.86

89.0

19

Illinois

0.7

257

383.41

232

347.28

90.6

25

Michigan

1.1

408

373.92

336

307.68

82.3

72

Ohio

0.9

640

690.88

582

628.89

91.0

58

Puerto Rico

0.6

117

209.25

102

182.53

87.2

15

South Carolina

0.4

151

379.20

138

347.23

91.6

13

Texas

1.1

734

696.46

645

611.78

87.8

89

Washington

2.4

688

280.85

603

246.36

87.7

85

Other (1) (2)

0.7

351

442.14

277

348.40

78.8

74

10.1

$

4,084

$

403.40

$

3,523

$

348.06

86.3

%

$

561

Three Months Ended September 30, 2018

California

1.9

$

484

$

253.96

$

483

$

253.60

99.9

%

$

1

Florida

1.2

454

382.20

407

341.70

89.4

47

Illinois

0.7

207

312.72

182

274.98

87.9

25

Michigan

1.1

409

345.28

328

276.88

80.2

81

New Mexico (2)

0.7

332

466.63

293

409.68

87.8

39

Ohio

1.0

611

616.95

550

555.83

90.1

61

Puerto Rico

1.0

179

189.65

162

171.96

90.7

17

South Carolina

0.4

124

354.53

112

318.56

89.9

12

Texas

1.3

805

611.01

659

500.14

81.9

146

Washington

2.3

555

239.25

478

206.38

86.3

77

Other (1)

0.5

177

336.18

136

260.19

77.4

41

12.1

$

4,337

$

358.46

$

3,790

$

313.23

87.4

%

$

547

Nine Months Ended September 30, 2019

California

5.4

$

1,682

$

312.08

$

1,387

$

257.25

82.4

%

$

295

Florida

1.4

570

404.81

455

323.37

79.9

115

Illinois

2.0

726

365.35

632

318.26

87.1

94

Michigan

3.3

1,226

372.58

1,005

305.29

81.9

221

Ohio

2.8

1,914

686.80

1,706

612.35

89.2

208

Puerto Rico

1.8

341

190.42

301

167.98

88.2

40

South Carolina

1.2

427

368.35

378

326.61

88.7

49

Texas

3.3

2,246

682.10

1,954

593.50

87.0

292

Washington

7.3

2,011

274.52

1,788

244.10

88.9

223

Other (1) (2)

2.2

942

413.13

754

330.48

80.0

188

30.7

$

12,085

$

393.52

$

10,360

$

337.37

85.7

%

$

1,725

Nine Months Ended September 30, 2018

California

5.9

$

1,617

$

275.64

$

1,388

$

236.61

85.8

%

$

229

Florida

3.7

1,358

372.07

1,136

311.09

83.6

222

Illinois

1.8

551

308.45

474

265.47

86.1

77

Michigan

3.5

1,201

338.83

1,006

283.77

83.7

195

New Mexico (2)

2.2

1,029

464.92

930

419.78

90.3

99

Ohio

3.0

1,754

583.29

1,532

509.52

87.4

222

Puerto Rico

2.9

549

190.34

501

173.83

91.3

48

South Carolina

1.1

369

350.94

323

306.76

87.4

46

Texas

4.1

2,394

581.74

1,994

484.70

83.3

400

Washington

7.0

1,805

257.82

1,649

235.59

91.4

156

Other (1)

1.6

547

334.26

429

262.27

78.5

118

36.8

$

13,174

$

358.42

$

11,362

$

309.12

86.2

%

$

1,812

__________________

(1) “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.

(2) In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

SELECTED FINANCIAL DATA

The following table provides details of the Company’s medical care costs for the periods indicated:

Three Months Ended September 30,

2019

2018

Amount

PMPM

% of

Total

Amount

PMPM

% of

Total

Fee for service

$

2,685

$

265.12

76.2

%

$

2,865

$

236.74

75.6

%

Pharmacy

412

40.74

11.7

495

40.90

13.1

Capitation

283

28.01

8.0

297

24.52

7.8

Other

143

14.19

4.1

133

11.07

3.5

$

3,523

$

348.06

100.0

%

$

3,790

$

313.23

100.0

%

Nine Months Ended September 30,

2019

2018

Amount

PMPM

% of

Total

Amount

PMPM

% of

Total

Fee for service

$

7,793

$

253.77

75.2

%

$

8,471

$

230.46

74.6

%

Pharmacy

1,254

40.83

12.1

1,645

44.76

14.5

Capitation

856

27.88

8.3

891

24.23

7.8

Other

457

14.89

4.4

355

9.67

3.1

$

10,360

$

337.37

100.0

%

$

11,362

$

309.12

100.0

%

The following table provides details of the Company’s medical claims and benefits payable as of the dates indicated:

September 30,

December 31,

2019

2018

Fee-for-service claims incurred but not paid (IBNP)

$

1,424

$

1,562

Pharmacy payable

128

115

Capitation payable

57

52

Other (1)

366

232

$

1,975

$

1,961

______________________

(1) “Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of September 30, 2019 and December 31, 2018, the Company had recorded non-risk provider payables of approximately $239 million and $107 million, respectively.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the original estimate of claims and benefits payable at the beginning of the period was more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

Nine Months Ended

Year Ended

September 30,

Dec. 31,

2018

2019

2018

Medical claims and benefits payable, beginning balance

$

1,961

$

2,192

$

2,192

Components of medical care costs related to:

Current period

10,613

11,670

15,478

Prior period (1)

(253

)

(308

)

(341

)

Total medical care costs

10,360

11,362

15,137

Change in non-risk and other provider payables

131

60

13

Payments for medical care costs related to:

Current period

8,996

9,866

13,671

Prior period

1,481

1,706

1,710

Total paid

10,477

11,572

15,381

Medical claims and benefits payable, ending balance

$

1,975

$

2,042

$

1,961

Days in claims payable, fee for service (2)

50

53

53

______________________

(1) The September 30, 2018, and December 31, 2018, amounts include the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.

(2) Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $42 million, $34 million and $43 million, as of September 30, 2019, September 30, 2018, and December 31, 2018, respectively.

SUMMARY OF NON-RUN RATE ITEMS AFFECTING CURRENT QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
(In millions, except per diluted share amounts)

The table below summarizes the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations. The individual items presented below increase (decrease) income before income tax expense.

Three Months Ended September 30,

Nine Months Ended September 30,

2019

2018

2019

2018

Amount

Per

Diluted

Share (1)

Amount

Per

Diluted

Share (1)

Amount

Per

Diluted

Share (1)

Amount

Per

Diluted

Share (1)

(Loss) gain on debt repayment

$

(2

)

$

(0.03

)

$

(10

)

$

(0.12

)

$

15

$

0.18

$

(25

)

$

(0.33

)

Restructuring costs

(5

)

(0.06

)

(5

)

(0.06

)

(38

)

(0.45

)

Gain on sale of subsidiary

37

0.42

37

0.43

$

(2

)

$

(0.03

)

$

22

$

0.24

$

10

$

0.12

$

(26

)

$

(0.35

)

______________________

(1) Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for 2019 and 2018, respectively.

NON-GAAP FINANCIAL MEASURES

The Company uses non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating the Company’s financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables.

Three Months Ended

Nine Months Ended

September 30,

September 30,

2019

2018

2019

2018

Net income

$

175

$

197

$

569

$

506

Adjustments:

Depreciation, and amortization of intangible assets and capitalized software

21

28

68

95

Interest expense

22

26

67

91

Income tax expense

58

62

181

237

EBITDA

$

276

$

313

$

885

$

929

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Earnings before interest, taxes, depreciation and amortization (“EBITDA”): Net income on a GAAP basis less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. The Company believes that EBITDA is helpful in assessing the Company’s ability to meet the cash demands of its operating units.

Three Months Ended September 30,

Nine Months Ended September 30,

2019

2018

2019

2018

Amount

Per

Diluted

Share

Amount

Per

Diluted

Share

Amount

Per

Diluted

Share

Amount

Per

Diluted

Share

Net income

$

175

$

2.75

$

197

$

2.90

$

569

$

8.80

$

506

$

7.60

Adjustment:

Amortization of intangible assets

4

0.07

6

0.08

13

0.21

16

0.23

Income tax effect (1)

(1

)

(0.02

)

(2

)

(0.01

)

(3

)

(0.05

)

(4

)

(0.05

)

Adjustment, net of tax effect

3

0.05

4

0.07

10

0.16

12

0.18

Adjusted net income

$

178

$

2.80

$

201

$

2.97

$

579

$

8.96

$

518

$

7.78

________________________

(1) Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:

Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.

Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

2019 REVISED GUIDANCE

Reconciliation of Non-GAAP Financial Measures

Low End

High End

(In millions)

Net income

$

725

$

740

Adjustments:

Depreciation, and amortization of intangible assets and capitalized software

90

90

Interest expense

90

90

Income tax expense

235

240

EBITDA

$

1,140

$

1,160

Investor Contact: Julie Trudell, [email protected], 562-912-6720

Media Contact: Caroline Zubieta, [email protected], 562-951-1588

Source: Molina Healthcare, Inc.

Categories

Business Wire Press Releases

Next Articles